Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PCM1::JAK2 with erythroblastic sarcoma: a case report and literature review

被引：0
|
作者：
Zhang, Lina [1 ]
Zhu, Xiaoqin [2 ]
Qu, Weiying [2 ]
Lu, Yingjia [2 ]
Feng, Zhou [2 ]
Zhao, Lin [2 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, Inst Basic Med, Dept Biochem, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Hematol, Shanghai, Peoples R China
来源：
REVISTA CHILENA DE LITERATURA | 2023年 / 108期
关键词：
FGFR1;
D O I：
10.3324/haematol.2022.282228
中图分类号：
I3/7 [各国文学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：3506 / 3510
页数：5
相关论文
共 50 条
  • [1] Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PCM1::JAK2 with erythroblastic sarcoma: a case report and literature review
    Zhang, Lina
    Zhu, Xiaoqin
    Qu, Weiying
    Lu, Yingjia
    Feng, Zhou
    Zhao, Lin
    HAEMATOLOGICA, 2023, 108 (12) : 3506 - 3510
  • [2] Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2
    Pozdnyakova, Olga
    Orazi, Attilio
    Kelemen, Katalin
    King, Rebecca
    Reichard, Kaaren K.
    Craig, Fiona E.
    Quintanilla-Martinez, Leticia
    Rimsza, Lisa
    George, Tracy, I
    Horny, Hans-Peter
    Wang, Sa A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (02) : 160 - 178
  • [3] Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?
    Bain, Barbara J.
    Ahmad, Shahzaib
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (06) : 809 - 817
  • [4] Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2
    Luedke, Catherine
    Rein, Lindsay
    BLOOD, 2020, 136 (09) : 1113 - 1113
  • [5] Myeloid sarcoma in JAK2-positive myelodysplastic neoplasms with fibrosis: a case report and literature review
    Bai, Jiaofeng
    Wang, Xuan
    Zheng, Ruirui
    He, Miao
    Zhang, Yuexia
    Zhang, Zhichen
    Yang, Xiaolan
    Pan, Yaozhu
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (08)
  • [6] Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
    Baer, Constance
    Muehlbacher, Verena
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    HAEMATOLOGICA, 2018, 103 (08) : E348 - E350
  • [7] Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia
    Metzgeroth, G.
    Schwaab, J.
    Naumann, N.
    Haferlach, C.
    Jawhar, M.
    Horny, H. -P.
    Dirk, J.
    Kratz-Albers, K.
    Kraemer, D.
    Mayer, S.
    Storch, N.
    Burchert, A.
    Haferlach, T.
    Cross, N. C. P.
    Hofmann, W. -K.
    Fabarius, A.
    Reiter, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [8] Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review
    Sun, Yingxin
    Cai, Yifeng
    Chen, Jia
    Cen, Jiannong
    Zhu, Mingqing
    Pan, Jinlan
    Wu, Depei
    Sun, Aining
    Chen, Suning
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
    Simone Romagnoli
    Niccolò Bartalucci
    Francesca Gesullo
    Manjola Balliu
    Stefania Bonifacio
    Anair Graciela Lema Fernandez
    Francesco Mannelli
    Davide Bolognini
    Elisabetta Pelo
    Cristina Mecucci
    Paola Guglielmelli
    Alessandro Maria Vannucchi
    Biomarker Research, 9
  • [10] Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
    Romagnoli, Simone
    Bartalucci, Niccolo
    Gesullo, Francesca
    Balliu, Manjola
    Bonifacio, Stefania
    Fernandez, Anair Graciela Lema
    Mannelli, Francesco
    Bolognini, Davide
    Pelo, Elisabetta
    Mecucci, Cristina
    Guglielmelli, Paola
    Vannucchi, Alessandro Maria
    BIOMARKER RESEARCH, 2021, 9 (01)
12345